Skip to main content
. Author manuscript; available in PMC: 2011 Apr 13.
Published in final edited form as: Microcirculation. 2008 Jul;15(5):461–471. doi: 10.1080/10739680701833804

Figure 5.

Figure 5

A: Effect of UT-15C (1 μM, n = 9) or its vehicle (CONTROL, saline) on cAMP levels in rabbit erythrocytes in the absence and presence of the IP receptor antagonist CAY10441 (CAY, 10 μM). B: Effect of iloprost (1 μM, n = 5) or its vehicle (CONTROL, saline) on cAMP levels in human erythrocytes in the absence and presence of the IP receptor antagonist CAY10441 (CAY, 10 μM). Values are means ± SE. *p < 0.01 compared to all other groups.

HHS Vulnerability Disclosure